Eason Technology ADR

Eason Technology said internal reviews found no indication of material, previously undisclosed information or operational disruptions, and that business operations are normal and compliant. The announcement came after unusual trading activity and a 15% drop in the stock last week to $0.48, roughly 95% below the 52‑week high. According to data, the stock trades at a price‑to‑book ratio of 0.19 and is considered oversold; additional metrics are available on InvestingPro. » More on de.investing.com

Eason Technology reports the resignation of board member Yuan Gao, stating the departure was not due to any disagreement with the company. Haitao He has been elected as the new member, subject to re-election at the next annual meeting, and is considered an independent director under NYSE American rules. Under his contract he will receive US$10,000 per month and is described as a pharmaceutical expert with more than ten years of experience in marketing, distribution channels and business operations; he has no familial relationships with executive officers or other directors. » More on de.investing.com

Eason Technology was censured by NYSE American for failing to comply with section 401(a) of the Company Guide: material transactions on December 16 and 29, 2025 were not reported in a timely manner. The company said it acknowledged the omission and will improve its procedures for disseminating material information to ensure future compliance. The stock trades at $1.43 and has recently dropped sharply (about 17% in the past week, roughly 66% over six months). » More on de.investing.com